Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. JOC [Internet]. 2011 Feb. 22 [cited 2025 Dec. 8];10(1). Available from: https://carcinogenesis.com/index.php/JOC/article/view/146